Aqualung Therapeutics Corporation

Aqualung Therapeutics Corporation

Private
Tucson, ArizonaHealthcare & Life Scienceshttps://www.aqualungtherapeutics.com/

Last Round

Grant

Sep 15, 2025

Total Funding Raised

$14.93M

Momentum Score

75 /100

Company Overview

Aqualung Therapeutics Corporation is a biotechnology company that develops an immune-focused biologic platform for serious inflammatory disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

monoclonal antibodyimmunotherapeuticsacute respiratory distress syndromeARDSeNAMPT inhibitormAb therapyclinical-stage biotechcytokine stormfibrosis treatmentanti-inflammatory drugprogressive pulmonary fibrosisPPFbiomarker panelventilator-induced lung injuryVILI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aqualung Therapeutics Corporation Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aqualung Therapeutics Corporation Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantSep 15, 2025
Series A ExtensionJul 18, 2023
Series AOct 1, 2022
GrantSep 21, 2022
Convertible DebtJan 18, 2022
Grant
Jun 2, 2020

Aqualung Therapeutics Corporation Investors

Notable investors and investment history

InvestorRounds
NIH RADxGrant
JSR Life SciencesConvertible Debt, Series A
DeepWork CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2026

    Monthly visitors grew 108% MoM, reaching 1.9K.

  • Sep 15, 2025

    $1.2M grant received from NIH RADx.

Aqualung Therapeutics Corporation Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aqualung Therapeutics Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aqualung Therapeutics Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersTucson, Arizona
Employee Range5
Year Founded2016
Last FundingSep 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.